Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sepsis patients in the ICU
IRCT20150706023084N22Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in sepsis comparing Melatonin with Placebo control (2 arms). Primary endpoints: Mortality, Morbidity based on SOFA score and 1 more. Started Oct 2024; status: completed.
02
Drugs
melatonin
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20150706023084N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023084N22.